PharmaCube
医药魔方
elsewhere's corpus does not cover PharmaCube — the entity exists in our index, but there is no reporting about the company itself (its founding, focus, or backers), and the retrieved material only touches on the broader AI-drug-discovery space (Insilico Medicine's Pharma.AI pipeline, DeepWise's molecular simulation platform, METiS's AI formulation work), none of which involves PharmaCube. Rather than stitch together a plausible-sounding profile, we'd rather point you to the results below and be upfront that this company isn't one we've written about.
AI-generated — may contain errors, please verify.
Coverage
Qiming Venture Partners | Connecting World-Class Science with Top Investors: Second Round of Startup Proposals Open for Inaugural S2S China Symposium
We sincerely invite top scientists to visit the S2SChina website and submit proposals, embarking on an accelerated journey from the lab to entrepreneurship.
Qiming Venture Partners and Eight Portfolio Companies Named to China Innovative Drug Decade Honors List
The list aims to honor outstanding institutions, companies, and major innovations that have delivered exceptional performance over the past decade while playing a significant leading and driving role in the upgrade of China's innovative pharmaceutical industry — establishing benchmarks for the sector's next ten-year journey.
Qiming Perspective | Qiming Venture Partners' Kan Chen: China's Innovative Drug Exports Hit Record Highs, Where Is Innovative Drug Investment Heading?
Beyond its homegrown efficiency advantages, China's biotech sector must also seize the opportunities presented by global collaborative clinical development in the years ahead — leveraging strengths across different regions worldwide to maximize biotech value creation.
Qiming Venture Partners and Four Portfolio Companies Named to PharmCube TOP15 Annual Awards
The awards aim to establish benchmark investment institutions and enterprises with annual bellwether significance for China's pharmaceutical industry.
Four Decades of China's Healthcare System: A Journey from Past to Future | FreeS Fund Report
Finding Innovation Opportunities Behind Transformation
